STRIDES PHARMA SCIENCE Q2 FY27 (CONS.) ; NET PROFIT UP 1.97% AT ₹13.41 CR (YOY), DOWN 18.96% (QOQ)

REVENUE UP 17.11% AT ₹142.97 CR (YOY), UP 12.99% (QOQ) EBITDA UP 8.35% AT ₹25.09 CR (YOY), UP 9.20% (QOQ) MARGINS AT 17.55% VS 18.97% (YOY), 18.16% (QOQ)

STRIDES PHARMA SCI LTD

← Back to feed